Test Price
2,800 AED✅ Home Collection Available
CACNA1C Gene Long QT Syndrome Type 8 Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين CACNA1C لكشف متلازمة كيو تي الطويلة من النوع الثامن في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
Executive Summary & Clinical Integrity
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via Next-Generation Sequencing (NGS) processed under ISO 9001:2015 Certified Laboratory (Cert: INT/EGQ/2509DA/3139).
- Premium Logistics: Paid Hospital-Grade Home Collection (8 AM‑11 PM) with ISO Certified Cold‑Chain handling and VIP Mobile Phlebotomy – ensuring sample integrity from your doorstep.
- Clinical Guidance: Complimentary telephonic post‑test counselling with a clinical geneticist or cardiologist to interpret results and plan next steps.
- Insurance & Billing: Direct billing verification via WhatsApp at +971 54 548 8731. We handle prior approvals for major UAE networks.
نحن نقدم خدمة جمع العينات المنزلية من الساعة 8 صباحًا حتى 11 مساءً، مع ضمان سلسلة تبريد معتمدة، واستشارة هاتفية بعد الفحص لمساعدتك في فهم النتائج وتوجيه الرعاية القلبية والجينية.
Test Overview
This genetic test employs advanced Next-Generation Sequencing to analyse the entire coding region of the CACNA1C gene, identifying pathogenic variants responsible for Long QT Syndrome Type 8 (Timothy syndrome). It provides definitive molecular confirmation and guides family cascade screening, reproductive planning, and personalised cardiac surveillance strategies.
| Feature | Our Test (NGS) | Closest Alternative (Single‑Gene Sequencing) |
|---|---|---|
| Precision | Full gene coverage + flanking intronic regions (99.9% sensitivity) | Targeted mutation hotspots only (~85% sensitivity) |
| Method | Illumina® Next-Generation Sequencing (NGS) with Sanger confirmation of all variants | Sanger sequencing of limited exons |
| Turnaround Time | 3‑4 weeks from receipt of sample | 6‑8 weeks |
*Based on internal validation against external proficiency testing samples.
Physician Insight & Safety Protocol
“This test can reveal important hereditary heart rhythm information, but I always stress that a CACNA1C variant must be interpreted in the context of a full cardiac work‑up, including ECG and clinical history. My team and I are here to help you integrate these results safely, never to replace ongoing cardiology care.”
— Dr. PRABHAKAR REDDY, DHA License: 61713011 (Consultant Cardiologist & Electrophysiologist)
⚠️ Medication Warning
Do not discontinue prescribed medication (e.g., beta‑blockers, anti‑arrhythmics) without consulting your doctor. Genetic test results alone do not determine treatment changes.
Exclusion Criteria & Emergency Red Flags
- Unable to provide informed consent (guardian consent mandatory for minors under UAE CDS Law 2026).
- Acute psychiatric crisis or cognitive inability to understand genetic implications.
- Known current adverse reaction to venipuncture that prevents blood draw (in such cases, FTA card collection may be arranged).
- If you experience sudden fainting, seizures, or sustained palpitations before or during the testing process, seek emergency medical attention immediately — this test is not a substitute for acute care.
Frequently Asked Questions
1. What exactly does the CACNA1C gene test detect?
This test detects DNA variants in the CACNA1C gene that cause Long QT syndrome type 8, a potentially life‑threatening heart rhythm disorder. The analysis covers all coding exons and adjacent intron boundaries using Next-Generation Sequencing, with all reported variants confirmed by Sanger sequencing. A positive result can trigger cascade screening in at‑risk relatives and guide implantation of cardioverter‑defibrillators when appropriate.
يكشف هذا التحليل عن التغيرات الجينية في جين CACNA1C المسؤول عن متلازمة كيو تي الطويلة من النوع الثامن، مما يسمح بتوجيه الفحص العائلي وتحديد العلاج الوقائي.
2. Who should consider undergoing this genetic test?
Individuals with a personal or family history of unexplained sudden cardiac arrest, syncope, or prolonged QT interval on ECG should strongly consider this test. It is also valuable for asymptomatic relatives of a confirmed Timothy syndrome patient, competitive athletes undergoing pre‑participation cardiac screening, and families planning pregnancy when one partner carries a known CACNA1C variant. All candidates must receive pre‑test genetic counselling in accordance with Federal Decree‑Law No. 41 of 2024.
ينصح بهذا الفحص للأفراد الذين لديهم تاريخ شخصي أو عائلي للإغماء غير المبرر أو السكتة القلبية المفاجئة، وللأقارب الذين يحملون طفرة مؤكدة، وبتوجيه من استشاري الجينات قبل الفحص.
3. How is the sample collected and what should I expect about turnaround time?
One blood sample or buccal swab is collected by a certified phlebotomist during a scheduled home visit, with a typical result delivery of 3 to 4 weeks. Whole blood, extracted DNA, or a single drop of blood on an FTA card are all acceptable specimens. The home collection service operates daily from 8 AM to 11 PM, and your sample is transported under cold‑chain conditions to our ISO‑certified laboratory. Once sequencing is complete, a detailed clinical report is issued and explained during your post‑ telephone consultation.
يتم جمع العينة بواسطة ممرض متخصص في منزلك، وتكون النتيجة جاهزة خلال 3 إلى 4 أسابيع، تليها استشارة هاتفية لتفسير التقرير مع أخصائي الجينات أو القلب.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians